FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:MAN1A2-PTGFRN

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: MAN1A2-PTGFRN
FusionPDB ID: 51069
FusionGDB2.0 ID: 51069
HgeneTgene
Gene symbol

MAN1A2

PTGFRN

Gene ID

10905

5738

Gene namemannosidase alpha class 1A member 2prostaglandin F2 receptor inhibitor
SynonymsMAN1BCD315|CD9P-1|EWI-F|FPRP|SMAP-6
Cytomap

1p12

1p13.1

Type of geneprotein-codingprotein-coding
Descriptionmannosyl-oligosaccharide 1,2-alpha-mannosidase IBalpha-1,2-mannosidase IBalpha1,2-mannosidaseprocessing alpha-1,2-mannosidase IBprostaglandin F2 receptor negative regulatorCD9 partner 1glu-Trp-Ile EWI motif-containing protein Fprostaglandin F2-alpha receptor regulatory proteinprostaglandin F2-alpha receptor-associated protein
Modification date2020031320200313
UniProtAcc

O60476

Main function of 5'-partner protein: FUNCTION: Involved in the maturation of Asn-linked oligosaccharides. Progressively trim alpha-1,2-linked mannose residues from Man(9)GlcNAc(2) to produce Man(5)GlcNAc(2).
.
Ensembl transtripts involved in fusion geneENST idsENST00000356554, ENST00000482811, 
ENST00000496699, ENST00000393203, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score12 X 11 X 7=9244 X 4 X 3=48
# samples 214
** MAII scorelog2(21/924*10)=-2.13750352374993
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(4/48*10)=-0.263034405833794
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: MAN1A2 [Title/Abstract] AND PTGFRN [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: MAN1A2 [Title/Abstract] AND PTGFRN [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)MAN1A2(117984947)-PTGFRN(117529423), # samples:3
Anticipated loss of major functional domain due to fusion event.MAN1A2-PTGFRN seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MAN1A2-PTGFRN seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:117984947/chr1:117529423)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across MAN1A2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across PTGFRN (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000356554MAN1A2chr1117984947+ENST00000393203PTGFRNchr1117529423+524316857351790351

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000356554ENST00000393203MAN1A2chr1117984947+PTGFRNchr1117529423+0.0005831940.9994168

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for MAN1A2-PTGFRN

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
MAN1A2chr1117984947PTGFRNchr11175294231685316TPTGIPWAMVNLKSAERLQVSLADRR

Top

Potential FusionNeoAntigen Information of MAN1A2-PTGFRN in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MAN1A2-PTGFRN_117984947_117529423.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MAN1A2-PTGFRNchr1117984947chr11175294231685HLA-A74:11MVNLKSAER0.96860.5693817
MAN1A2-PTGFRNchr1117984947chr11175294231685HLA-A74:03MVNLKSAER0.96860.5693817
MAN1A2-PTGFRNchr1117984947chr11175294231685HLA-A74:09MVNLKSAER0.96860.5693817
MAN1A2-PTGFRNchr1117984947chr11175294231685HLA-A31:02MVNLKSAER0.8370.5198817
MAN1A2-PTGFRNchr1117984947chr11175294231685HLA-B57:03KSAERLQVSL0.99630.97831222
MAN1A2-PTGFRNchr1117984947chr11175294231685HLA-C15:05KSAERLQV0.99990.77931220
MAN1A2-PTGFRNchr1117984947chr11175294231685HLA-C15:02KSAERLQV0.99990.77411220
MAN1A2-PTGFRNchr1117984947chr11175294231685HLA-A74:01MVNLKSAER0.96860.5693817
MAN1A2-PTGFRNchr1117984947chr11175294231685HLA-B78:02WAMVNLKSA0.8370.782615

Top

Potential FusionNeoAntigen Information of MAN1A2-PTGFRN in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MAN1A2-PTGFRN_117984947_117529423.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1113MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1117MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1117AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1117WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1117VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1152MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1152AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1152WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1152VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1189MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1189AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1189WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1401MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1401WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1401AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1401VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1404MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1404WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1404AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1405MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1405AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1405WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1405VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1407MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1407WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1407AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1408MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1408AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1408WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1408VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1411MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1411AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1411WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1414MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1418MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1418AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1418WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1418VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1423MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1423AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1423WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1423VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1426MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1426WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1426AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1426VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1428MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1428WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1428AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1431MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1432MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1432AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1432WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1434MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1435MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1435AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1435WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1436MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1438MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1438AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1438WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1438VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1439MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1439WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1439AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1442MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1443MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1443AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1443WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1443VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1444MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1445MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1445AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1445WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1445VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1450MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1450AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1450WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1454MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1454WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1454AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1454VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1455MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1455WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1455AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1456MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1456AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1456WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1456VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1458MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1458WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1458AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1458VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1459MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1459AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1459WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1459VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1460MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1460WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1460AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1460VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1461MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1461WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1461AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1462MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1462WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1462AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1462VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1464MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1464AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1464WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1470MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1470WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1470AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1471MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1471WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1471AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1472MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1472AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1472WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1475MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1475WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1475AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1475VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1481MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1482MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1482WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1482AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1482VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1486MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1486WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1486AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1486VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1487MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1487WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1487AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1487VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1488MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1488WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1488AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1488VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1490MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1490WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1490AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1490VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1491MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1491AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1491WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1491VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1495MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1495WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1495AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1496MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1496AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1496WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1496VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1497MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1497WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1497AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1497VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1499MVNLKSAERLQVSLA823
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1499AMVNLKSAERLQVSL722
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1499WAMVNLKSAERLQVS621
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB1-1499VNLKSAERLQVSLAD924
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB5-0205PWAMVNLKSAERLQV520
MAN1A2-PTGFRNchr1117984947chr11175294231685DRB5-0205IPWAMVNLKSAERLQ419

Top

Fusion breakpoint peptide structures of MAN1A2-PTGFRN

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
10424WAMVNLKSAERLQVMAN1A2PTGFRNchr1117984947chr11175294231685

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of MAN1A2-PTGFRN

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN10424WAMVNLKSAERLQV-7.9962-8.1096
HLA-B14:023BVN10424WAMVNLKSAERLQV-5.70842-6.74372
HLA-B52:013W3910424WAMVNLKSAERLQV-6.83737-6.95077
HLA-B52:013W3910424WAMVNLKSAERLQV-4.4836-5.5189
HLA-A11:014UQ210424WAMVNLKSAERLQV-10.0067-10.1201
HLA-A11:014UQ210424WAMVNLKSAERLQV-9.03915-10.0745
HLA-A24:025HGA10424WAMVNLKSAERLQV-6.56204-6.67544
HLA-A24:025HGA10424WAMVNLKSAERLQV-5.42271-6.45801
HLA-B44:053DX810424WAMVNLKSAERLQV-7.85648-8.89178
HLA-B44:053DX810424WAMVNLKSAERLQV-5.3978-5.5112
HLA-B35:011A1N10424WAMVNLKSAERLQV-6.27422-6.38762
HLA-B35:011A1N10424WAMVNLKSAERLQV-5.27424-6.30954
HLA-A02:016TDR10424WAMVNLKSAERLQV-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of MAN1A2-PTGFRN

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
MAN1A2-PTGFRNchr1117984947chr11175294231220KSAERLQVAAGTGCTGAACGCCTTCAAGTATC
MAN1A2-PTGFRNchr1117984947chr11175294231222KSAERLQVSLAAGTGCTGAACGCCTTCAAGTATCCCTTGC
MAN1A2-PTGFRNchr1117984947chr1117529423615WAMVNLKSAGGCAATGGTGAATTTGAAAAGTGCTGA
MAN1A2-PTGFRNchr1117984947chr1117529423817MVNLKSAERGGTGAATTTGAAAAGTGCTGAACGCCT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
MAN1A2-PTGFRNchr1117984947chr1117529423419IPWAMVNLKSAERLQTCCTTGGGCAATGGTGAATTTGAAAAGTGCTGAACGCCTTCAAGT
MAN1A2-PTGFRNchr1117984947chr1117529423520PWAMVNLKSAERLQVTTGGGCAATGGTGAATTTGAAAAGTGCTGAACGCCTTCAAGTATC
MAN1A2-PTGFRNchr1117984947chr1117529423621WAMVNLKSAERLQVSGGCAATGGTGAATTTGAAAAGTGCTGAACGCCTTCAAGTATCCCT
MAN1A2-PTGFRNchr1117984947chr1117529423722AMVNLKSAERLQVSLAATGGTGAATTTGAAAAGTGCTGAACGCCTTCAAGTATCCCTTGC
MAN1A2-PTGFRNchr1117984947chr1117529423823MVNLKSAERLQVSLAGGTGAATTTGAAAAGTGCTGAACGCCTTCAAGTATCCCTTGCTGA
MAN1A2-PTGFRNchr1117984947chr1117529423924VNLKSAERLQVSLADGAATTTGAAAAGTGCTGAACGCCTTCAAGTATCCCTTGCTGATCG

Top

Information of the samples that have these potential fusion neoantigens of MAN1A2-PTGFRN

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
UCECMAN1A2-PTGFRNchr1117984947ENST00000356554chr1117529423ENST00000393203TCGA-FI-A3PV-01A

Top

Potential target of CAR-T therapy development for MAN1A2-PTGFRN

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneMAN1A2chr1:117984947chr1:117529423ENST00000356554+61337_57316642.0TransmembraneHelical%3B Signal-anchor for type II membrane protein
TgenePTGFRNchr1:117984947chr1:117529423ENST0000039320379833_8530880.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to MAN1A2-PTGFRN

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to MAN1A2-PTGFRN

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource